mia responses. 1,2 Although donor T cells are clearly responsible for the initiation of GVHD, both the afferent and efferent phases of the disease appear to be dominated by The incidence and severity of GVHD following bone marrow transplantation increases with recipient age.
2,5
Several risk factors including alloimmune female into (C57BL/6 ؋ DBA/2)F1) murine GVHD system. Young adult (2 months) and old (12-14 months) recipient mice male transplantation, degree of HLA identity, age of the recipient, GVHD prophylaxis and BM dose have been were lethally irradiated and reconstituted with young adult T cell-depleted bone marrow (ATBM) or ATBM shown to be associated with an increased risk of developing acute and chronic GVHD. 6, 7 In older patients, an increased and young spleen cells. A significantly higher percentage of old vs young recipients developed lethal GVHD. Furincidence of and mortality from GVHD has been observed. [8] [9] [10] [11] This age-related increase in GVHD has been thermore, while pre-transplant conditioning with irradiation was not required to observe increased morshown to occur as early as 20 years and is of such magnitude by 50 years of life, that few BM transplants are done tality in old recipients, irradiation predisposed the older animals for a more severe course of GVHD, suggesting despite its potential usefulness in the treatment of many neoplastic diseases. 1, 8, 9 With these findings in mind, it has that GVHD occurred in old compared to young animals in the absence of pre-transplant conditioning but was been proposed that the increased incidence of GVHD in old recipients may be the result of altered tolerance induction exacerbated by irradiation. Histologically, the immunological responses in the GVHD target organs were more following BMT.
12
While numerous clinical studies cite recipient age as a severe in the old GVHD animals. In support of this observation, increased spontaneous proliferation was major predisposing factor for GVHD, little to no research has been conducted in animal models to address this issue. observed using lymphoid cells isolated from old vs young GVHD mice. These findings demonstrate that old Previous studies have concentrated on donor age, where Uphoff 13 found no association between increasing donor recipients develop a more severe course of GVHD following BMT, and may present a unique opportunity to age and the risk of GVHD in mice. In this report, we describe the development of a murine GVHD model to study age-related factors in the generation of GVHD. Keywords: bone marrow transplantation; recipient age; address the role of recipient age in the GVHD process. Data will be presented demonstrating that old irradiated recipigraft-versus-host disease ents of young donor lymphoid cells have a higher incidence of acute GVHD than young adult animals of the same strain combination. Concomitant with these findings was an Bone marrow transplantation has been used to treat a wide increase in the severity of GVHD-induced pathology in variety of hematologic, oncologic and metabolic disorders. many of the target organs of acute GVHD. Finally, host A significant cause of morbidity and mortality following irradiation was required for enhanced GVHD mediated allogeneic BMT is chronic or acute GVHD caused by lethality in old mice. mature T cells contaminating the marrow graft. [1] [2] [3] [4] Graftversus-host disease can be reduced or eliminated by removal of T cells from the donor graft. However, transplantation of T cell-depleted allogeneic marrow results in Materials and methods decreased donor cell engraftment and increased relapse rates for various malignancies, suggesting a role for donor T cells in engraftment and potentially, graft-versus-leukeMice Laboratories (Bar Harbor, ME, USA tions and stained with hematoxylin and eosin. All histopathology slides were coded and graded by the reader in or 5 ϫ 10 6 young adult B6 spleen cells as a source of donor T cells (GVHD mice). Control recipients received 1 ϫ 10 7 random order independent of individual treatment groups. After initial grading of all samples, the slides were young adult B6 ATBM cells alone (ATBM mice). To analyze the effects of recipient irradiation on the induction of reviewed in a single day to ensure uniformity of grading. Grading was based on the predominant finding. Cases GVHD in this system, non-irradiated young and old B6D2F1 recipient animals were reconstituted with 1 ϫ 10 8 which were predominantly one grade but contained clear small foci of the next higher grade were graded halfway or 5 ϫ 10 7 young adult B6 spleen cells. Following transplantation, the mice were weighed three times weekly and between the two grades. Evaluation of the results revealed the presence of rare degenerated basal cells in ATBM conobserved for mortality and clinical signs of GVHD (runting (weight loss), hunched posture, dermatitis or diarrhea).
trol and test animals alike, giving a background of approximately 0.5 in all epithelial tissues. Also, in ATBM control Moribund animals were killed by CO 2 asphyxiation and counted as mortalities.
animals, modest portal lymphocytic infiltrate without bile duct damage was generally present, giving a background grade of approximately 1.0 in the liver. It is unlikely that these lesions are related to GVHD and may be conditionEngraftment ing-related or linked to other non-specific mechanisms. Details of the grading system are summarized below. Engraftment of donor cells following induction of GVHD was determined by flow cytometric analysis of spleen cell Liver suspensions for donor and recipient MHC class I molecule 0.5: focal mild portal lymphoid infiltrate; expression. At 5 and 21 days after induction of GVHD, 1ϩ: widespread mild portal lymphoid infiltrate; young and old GVHD mice were killed, spleens removed 2ϩ: focal bile duct invasion or cellular injury; and single cell spleen cell suspensions were prepared. The 3ϩ: multiple foci of bile duct injury and regeneration; cell suspensions were depleted of erythrocytes by lysis with 4ϩ: widespread injury and destruction of bile ducts. 0.83% Tris-buffered ammonium chloride, then washed 2ϫ in RPMI 1640 containing 5% FCS. Two color flow cytome-GI -small and large intestine 0. 
Statistical analysis
Survival analysis was performed using the log rank test. 
Results
Numerous clinical studies have demonstrated that increasing recipient age is one of the predominant risk factors for the development of severe GVHD. [8] [9] [10] [11] At this time, however, there are minimal experimental data addressing this issue. A murine P → F1 GVHD model was utilized to determine the effect of increasing recipient age on the development of GVHD. 
Development of acute GVHD in old recipients
To determine the appropriate age of recipients for these studies, life span tables for humans and mice were used. Patients have been shown to be at an increased risk for the development of severe GVHD as early as 20-30 years of age. Using the lifespan estimates, 12 to 14-month-old mice were chosen to approximate the age at which clinical risk occurs. To induce acute GVHD, lethally irradiated, young adult (2-3 months) and old (12-14 months) B6D2F1 mice were reconstituted with young adult B6 ATBM and varying numbers of young adult B6 spleen cells. Control animals were injected with ATBM alone. GVHD-induced mortality (Figure 1a and b) . The increased mortality observed in the CD8 ϩ ) GVHD mice given 10 7 B6 ATBM and 10 7 B6 spleen cells. By 21 days after initiation of GVHD, mortality old GVHD mice appeared not to be a result of differences in the engraftment of donor cells in the young and old was observed in old animals receiving 10 7 donor spleen cells (Figure 1b) . recipient animals since similar percentages of donor T cells Figure 2 , significantly enhanced GVHD-mediated mortality was observed in the B6 spleen cells compared to non-irradiated young recipient mice receiving the same donor cell dose. These results sugaged (P ϭ 0.0027) and old (0.0020) recipients compared to the young adult recipient animals. However, there was gested that an enhanced donor anti-recipient immune response may have occurred in the older recipient GVHD no apparent difference based on clinical symptoms as measured by weight loss (data not shown) or mortality between mice independent of conditioning (see below). In contrast, conditioning with irradiation prior to BMT resulted in the aged and old GVHD groups (P ϭ 0.13). All control ATBM-transplanted animals survived to the end of the increased mortality in both young and old recipient animals ( Figure 1 vs Figure 3) ; the increase in mortality being experiment at day 65 post-BMT. These findings suggested that a threshold age may exist at which the enhanced enhanced to a greater extent in the older GVHD mice (Figure 1 ). GVHD response is observed, and that irradiated older recipients of allogeneic BM and spleen cells developed enhanced GVHD when compared to young adult animals receiving the same donor cells in an acute GVHD system.
Histological analysis of acute GVHD in old and young recipients
The data presented above suggest that a more severe course 14 With this in mind, experiwere analyzed 21 days after BMT. The target organs for acute GVHD: skin, liver, intestines, ments were initiated to determine the role of recipient irradiation on the enhanced GVHD in old mice. Using the P tongue 15 in both young and old animals receiving spleen cells showed markedly increased immunological responses → F1 GVHD model described above, non-irradiated young adult and old B6D2F1 mice were injected with 1 ϫ 10 8 or compared to their respective ATBM controls (Table 1) . Additionally, significant differences were observed in the 5 ϫ 10 7 (data not shown) young adult parental B6 spleen severity of GVHD in the liver, skin and ear tissue isolated from old vs young recipients ( Table 1 ). The example of liver pathology presented in Figure 4 illustrates the mean malignancies in younger patients have been successfully c The P values presented were determined using Student's t-test.
treated by BMT. [19] [20] [21] [22] [23] [24] However, BMT is generally not utilized in patients greater than 60 years of age due to the detrimental effects of GVHD. 25, 26 At this time, little graded score of each group rather than the extremes. The livers of young ( Figure 4a ) and old ( Figure 4c ) ATBM conresearch has been conducted in animal models to address this issue. The data presented in this report are the first to trols had only minimal portal infiltrates. However, the young GVHD mice (Figure 4b ) showed a significant portal analyze the effect of recipient age on the development of GVHD following allogeneic BMT. Using a semi-allogeneic infiltrate with bile duct invasion and damage when compared to control animals. In contrast, the old GVHD ani-P → F1 (acute GVHD) murine GVHD system, it was demonstrated that old recipient animals developed a more sevmals (Figure 4d ) demonstrated near complete bile duct destruction in this area. Generally, the immunological ere course of acute GVHD as measured by a decrease in median survival time and an increase in mortality when responses present in old GVHD recipients were more severe than in the young counterparts based on the histological compared to young adult recipients. Moreover, significant mortality was observed in unirradiated old but not young GVHD grade (P ϭ 0.00097; Table 1 ). The major difference illustrated between the liver pathology from young and old GVHD animals with this effect being exacerbated by pretransplant conditioning. Concomitantly, an intensified GVHD mice was the relative preservation of bile duct integrity in the young animals.
immunological response was observed in lymphoid organs and target tissues from old mice with acute GVHD comIn contrast to the histological results described above, when tissue samples from tongue and small and large intespared to their younger counterparts. Several risk factors have been identified for the developtine were graded, no statistical differences in the intensity of GVHD-related pathology were observed between young ment of GVHD following BMT. 6, 7 Older patients have been shown to be at increased risk for the development of severe and old GVHD animals (data not shown). However, the pathology found in the small and large intestine revealed GVHD. In a multivariate analysis of risk factors for acute GHVD following histocompatible donor BMT, Weisdorf et that old GVHD mice had more severe lesions which appeared to be different from those in younger GVHD anial 9 demonstrated that patient age у18 years of age was the dominant factor independently and significantly associated mals and approached significance in the small intestine (P ϭ 0.088). Thus, based on the GVHD grading system with acute GVHD. No age gradient was observed within the adult population. In an analysis of transplants performed described in the Materials and methods section, the GVHDinduced pathology in the target organs (liver, skin, tongue, from unrelated donors through the National Marrow Donor Program, Kernan et al 10 demonstrated that the development GI tract) was more severe in the old recipients following induction of acute GVHD.
of grade III to IV acute GVHD was independently associated with the use of marrow that had not been T cell depleted and increasing patient age. Similarly, in a retrospective study, Klingemann et al 8 have shown that the incidence of Proliferative responses in old GVHD mice grade II-IV acute GVHD was 79% in patients of 50 years of age, compared to 30% for younger patients, leading to In the B6 → B6D2F1 acute GVHD model, both CD4 ϩ and CD8 ϩ anti-recipient immune responses have been the conclusion that allogeneic BMT should not be a first line therapy for hematologic malignancies in patients more described. 16 One explanation for the severity of the GVHD and GVHD-induced pathology observed in aged and old than 50 years of age. With numerous studies citing increasing patient age as a risk factor for the development of recipient animals is that enhanced donor anti-recipient immune responses occurred in these animals. To address GVHD following allogeneic BMT, it should be noted that exceptions do exist. In a recent European study, recipient this possibility, preliminary experiments were performed to monitor the spontaneous proliferative responses of cells age was found not to be associated with the development of grade II-IV acute GVHD. 27 isolated from the spleens of old (12-14 months) and young The mechanism(s) responsible for the effect of recipient currently under investigation. Second, enhanced donor antirecipient immune responses may have occurred in vivo in age on the development of GVHD following allogeneic BMT is unknown. Several factors may be responsible for the older recipients following induction of GVHD. Immune cells isolated from irradiated old GVHD mice demonstrated the age effect associated with GVHD. First, it has recently been shown that normal aged animals had elevated serum enhanced in vitro spontaneous proliferation suggesting that increased numbers of cells were activated in vivo. The natlevels of IL-6 when compared to young adult mice. 28 In addition, Xun et al 14 have demonstrated that pretransplant ure of the activated cells is the basis of future work. In addition, preliminary studies have demonstrated that anticonditioning with irradiation resulted in enhanced production of TNF-␣, IL-1 and IL-6. While recipient recipient proliferative responses of purified T cells from old GVHD animals against recipient antigens appear to be irradiation was not a prerequisite for the enhanced GVHD mortality observed in the present study, pre-transplant conincreased (unpublished data). Enhanced responsiveness in vivo, in part, could account for increased levels of cytokines ditioning with irradiation increased the severity of GVHD in old recipients such that up to 20-fold fewer donor spleen during the 'cytokine storm' 5 of the acute GVHD response in the older recipient animals. Finally, it is likely that cells cells were required to elicit maximal mortality following BMT. Therefore, old recipients may have an enhanced and/or tissues from older animals may have an enhanced ability to stimulate immune responses. Sidman et al 30 have capacity to produce proinflammatory cytokines following conditioning. These cytokines have the ability to upregulate shown that lymphoid cells from old mice have increased MHC expression and displayed a greater capacity to stimuthe expression of MHC and cellular adhesion molecules in target organs. 5, 14 Enhanced expression of such molecules late an allogeneic mixed lymphocyte reaction in vitro compared to cells isolated from young adult animals. We have in aged recipients could lead to increased activation and/or migration of donor GVHD effector cells to the target tissues repeated these findings 30 and have demonstrated that irradiated spleen cells isolated from old (12-14 months) of the disease. Alternatively, old recipients may be more sensitive to the direct adverse effects of the proinflamma-B6D2F1 mice have an increased capacity over spleen cells from young F1 mice to stimulate B6 T cells in vitro tory cytokines 29 which are produced following irradiation and/or activation of donor T cells during the acute GVHD (unpublished data). These findings suggest that cells and target organs from old animals serve as more efficient disease process. 2, 5 Based on the data at hand, these possibilities cannot be distinguished at the present time and are stimulators and/or targets for the immune responses which 
